Latest Breaking News On - Accord healthcare ltd - Page 2 : comparemela.com

MHRA Approves Anastrozole for Post-Menopausal Breast Cancer Prevention

MHRA Approves Anastrozole for Post-Menopausal Breast Cancer Prevention
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United kingdomRegulatory agencyAccord healthcare ltdYellow cardGoogle playApple appAccord healthcare

Intas Pharmaceuticals Ltd and Henlius Biotech enter into Exclusive License Agreement to commercialise serplulimab

Intas Pharmaceuticals Ltd and Henlius Biotech enter into Exclusive License Agreement to commercialise serplulimab
webindia123.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webindia123.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesSouth africaPaul tredwellTuzucip trastucipAsia pacificBinish chudgarJason zhuShanghai henlius biotech incJournal of the american medical associationEuropean medicines agencyEuropean commissionIntas pharmaceuticals ltdIntas pharmaceuticals limitedDrug administrationAccord healthcare ltd

Increasing Prevalence of Laryngeal Cancer Fuels Growth in Laryngeal Cancer Therapeutics Market

/PRNewswire/ The "Global Laryngeal Cancer Therapeutics Market 2023-2027" report has been added to ResearchAndMarkets.com s offering. The global laryngeal.

United statesLaura woodEli lillyHanmi pharm coTeva pharmaceutical industries ltdBayer agAthenex incBristol myers squibb coAmgen incOffice hours callF hoffmann la roche ltdPfizer incSun pharmaceutical industries ltdRegeneron pharmaceuticals incHikma pharmaceuticals plcE st office hours call

Henlius Deepens Collaboration with Intas to bring Henlius Novel anti-PD-1 mAb Serplulimab to Europe and India

/PRNewswire/ Shanghai Henlius Biotech, Inc. (2696.HK) has entered into an exclusive license agreement with Intas Pharmaceuticals Limited ("Intas") for the.

United kingdomUnited statesSouth africaAsia pacificFosun pharmaPaul tredwellJason zhuBinish chudgarPrnewswire shanghai henlius biotech incEuropean commissionIntas pharmaceuticals limitedAccord healthcare ltdJournal of the american medical associationDrug administrationEuropean medicines agencyIntas pharmaceuticals ltd

Novartis settles one of two MS drug patent disputes

Action against generics group Mylan continues after terms agreed with rival generics player Accord Healthcare in patent infringement case

Justice denis mcdonaldPaul coughlanFingolimod mylanHigh courtMylan healthcare ltdMylan healthcare ireland ltdAccord healthcare ltdNovartis ireland ltdSpain based accord healthcareFingolimod accordMcdermott laboratoriesGerard laboratoriesMylan dublinAccord healthcare